Evidence map›Paper›PMID 24972706›Full record

ArticleBrain : a journal of neurology2014

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Sophie Tezenas du Montcel, Alexandra Durr, Peter Bauer, Karla P Figueroa, Yaeko Ichikawa, Alessandro Brussino, Sylvie Forlani, Maria Rakowicz, Ludger Schöls, Caterina Mariotti and 24 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 4 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 4 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Epidemiology of Spinocerebellar Ataxias in Europe.Cerebellum (London, England) · 2024
    Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Movement Disorders in Hereditary Cerebellar Ataxia.Movement disorders clinical practice · 2025
    Article
  18. Article
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 12 countries.

Sophie Tezenas du Montcel1 Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013, Paris, France2 INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013, Paris, France3 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Biostatistics Unit, Paris, F-75013, France sophie.tezenas@psl.aphp.fr alexis.brice@upmc.fr.
Alexandra Durr4 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Genetics and Cytogenetics, F-75013, Paris, France5 Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France.
Peter Bauer6 Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Karla P Figueroa7 Department of Neurology, University of Utah, Salt Lake City, USA.
Yaeko Ichikawa8 Department of Neurology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Alessandro Brussino9 University of Torino, Department of Medical Sciences, and Medical Genetics Unit, Az. Osp. 'Città della Salute e della Scienza', Torino, Italy.
Sylvie Forlani5 Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France.
Maria Rakowicz10 Institute of Psychiatry and Neurology Warsaw, Sobieskiego 9, 02-957 Warsaw, Poland.
Ludger Schöls11 Department of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany12 German Centre of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Caterina Mariotti13 SOSD Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS, Istituto Neurologico 'Carlo Besta', Milan, Italy.
Bart P C van de Warrenburg14 Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radbound University Medical Centre, Nijmegen, The Netherlands.
Laura Orsi15 Neurologic Division I, Department of Neuroscience and Mental Health, AOU Città della Salute e della Scienza, Torino, Italy.
Paola Giunti16 Institute of Neurology, Department of Molecular Neuroscience, UCL, Queen Square, London, UK.
Alessandro Filla17 Department of Neurological Sciences, Federico II University, Naples, Italy.
Sandra Szymanski18 Department of Neurology, St. Josef Hospital, University Hospital of Bochum, Bochum, Germany.
Thomas Klockgether19 Department of Neurology, University Hospital of Bonn, Bonn, Germany.
José Berciano20 Department of Neurology, University Hospital 'Marqués de Valdecilla', UC, IDIVAL and CIBERNED, 39008 Santander, Spain.
Massimo Pandolfo21 Department of Neurology, ULB-Hôpital Erasme, Université Libre de Bruxelles, CP 231, Campus Plaine, ULB, Brusssels, Belgium.
Sylvia Boesch22 Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Bela Melegh23 Department of Medical Genetics, and Szentagothai Research Centre, University Pécs, Hungary.
Dagmar Timmann24 Department of Neurology, University Clinic Essen, University of Duisburg-Essen, Essen, Germany.
Paola Mandich25 Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genova, and U.O. Medical Genetics of IRCCS AOU S. Martino Institute, Genova, Italy.
Agnès Camuzat5 Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France.
Clinical Research Consortium for Spinocerebellar Ataxia (CRC-SCA)
EUROSCA network
Jun Goto8 Department of Neurology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Tetsuo Ashizawa26 Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Cécile Cazeneuve4 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Genetics and Cytogenetics, F-75013, Paris, France.
Shoji Tsuji8 Department of Neurology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Stefan-M Pulst7 Department of Neurology, University of Utah, Salt Lake City, USA.
Alfredo Brusco9 University of Torino, Department of Medical Sciences, and Medical Genetics Unit, Az. Osp. 'Città della Salute e della Scienza', Torino, Italy.
Olaf Riess6 Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Alexis Brice4 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Genetics and Cytogenetics, F-75013, Paris, France5 Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France sophie.tezenas@psl.aphp.fr alexis.brice@upmc.fr.
Giovanni Stevanin4 AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Genetics and Cytogenetics, F-75013, Paris, France5 Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France27 Ecole Pratique des Hautes Etudes, heSam Université, laboratoire de neurogénétique, ICM, Groupe Hospitalier Pitié-Salpêtrière, F-75013 Paris, France.
Institut du Cerveau · FRThe University of Tokyo · JPUniversity of Tübingen · DEUniversity of Utah · USAssistance Publique – Hôpitaux de Paris · FRAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITCentre National de la Recherche Scientifique · FRFederico II University Hospital · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITInnsbruck Medical University · ATInstitute of Psychiatry and Neurology · PLInstituto de Investigación Marqués de Valdecilla · ESInstitut Pierre Louis d‘Épidémiologie et de Santé Publique · FRNational Hospital for Neurology and Neurosurgery · GBOspedale Policlinico San Martino · ITRadboud University Medical Center · NLSorbonne Université · FRSt. Josef-Hospital · DEUniversité Libre de Bruxelles · BEUniversity Hospital Bonn · DE

Funding

Identifying symptomatic and neuroprotective strategies for cerebellar ataxiaR01NS085054 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI SHAKKOTTAI, VIKRAM GOVINDARAJU · 2013 to 2023
$4.3M
Clinical Research Consortium for Spinocerebellar AtaxiasRC1NS068897 · NINDS · UNIVERSITY OF FLORIDA · PI ASHIZAWA, TETSUO · 2009 to 2010
$1.0M
The role of glucocerebrosidase and chaperone_mediated autophagy in Parkinsons disK08NS083738 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2013 to 2017
$940k
NINDS NIH HHS K08 NS083738NINDS NIH HHS NS068897NINDS NIH HHS R01 NS085054NINDS NIH HHS RC1 NS068897
6 · The paper itself

Abstract

Polyglutamine-coding (CAG)n repeat expansions in seven different genes cause spinocerebellar ataxias. Although the size of the expansion is negatively correlated with age at onset, it accounts for only 50-70% of its variability. To find other factors involved in this variability, we performed a regression analysis in 1255 affected individuals with identified expansions (spinocerebellar ataxia types 1, 2, 3, 6 and 7), recruited through the European Consortium on Spinocerebellar Ataxias, to determine whether age at onset is influenced by the size of the normal allele in eight causal (CAG)n-containing genes (ATXN1-3, 6-7, 17, ATN1 and HTT). We confirmed the negative effect of the expanded allele and detected threshold effects reflected by a quadratic association between age at onset and CAG size in spinocerebellar ataxia types 1, 3 and 6. We also evidenced an interaction between the expanded and normal alleles in trans in individuals with spinocerebellar ataxia types 1, 6 and 7. Except for individuals with spinocerebellar ataxia type 1, age at onset was also influenced by other (CAG)n-containing genes: ATXN7 in spinocerebellar ataxia type 2; ATXN2, ATN1 and HTT in spinocerebellar ataxia type 3; ATXN1 and ATXN3 in spinocerebellar ataxia type 6; and ATXN3 and TBP in spinocerebellar ataxia type 7. This suggests that there are biological relationships among these genes. The results were partially replicated in four independent populations representing 460 Caucasians and 216 Asian samples; the differences are possibly explained by ethnic or geographical differences. As the variability in age at onset is not completely explained by the effects of the causative and modifier sister genes, other genetic or environmental factors must also play a role in these diseases.

Indexed as

AdolescentAdultAgedAge of OnsetAsian PeopleChildCohort StudiesFemaleHumansMaleMiddle AgedSpinocerebellar AtaxiasTrinucleotide Repeat ExpansionWhite PeopleYoung Adultage at onsetmodifierspinocerebellar ataxiatrinucleotide repeat

Identifiers

PMID24972706
PMCPMC4132646
OpenAlexW2132539907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.